Global Blood Collection Devices Market Overview
The Global Blood Collection Devices Market is projected to grow at a CAGR of 7% between 2021 and 2026. Factors such as the increasing number of trauma and accident cases, the rising volume of surgical procedures worldwide, a surge in infectious diseases, supportive government initiatives for blood donation, and the expanding adoption of liquid biopsy tests are driving market growth.
Request Sample Pages: https://meditechinsights.com/blood-collection-devices-market/request-sample/
Blood collection is an essential process carried out through methods like venipuncture, arterial sampling, or fingerstick sampling. It plays a vital role in disease diagnosis, prevention, and treatment. Additionally, blood collected from donors during donation drives is separated into various components such as plasma, platelets, and red cells for use in transfusions and other medical procedures.
New Product Development Driving Market Adoption
Continuous innovation in blood collection technologies has led to the creation of more efficient and safer devices. Recent products integrate artificial intelligence (AI), ultrasound-guided 3D reconstruction, and user-friendly home collection systems that enable accurate and large-volume blood collection. Notable product developments include: In May 2022, Vitestro introduced an autonomous venipuncture system using AI and robotic needle insertion for precision and safety. In the same month, Labcorp launched an at-home HbA1c testing kit from Weavr Health through its Labcorp OnDemand platform, supporting diabetes risk assessment. Owen Mumford Ltd, in April 2022, unveiled three new Unistik devices—ShieldLock, ShieldLock Ultra, and VacuFlip—designed for safe, high-volume venous blood draws while minimizing the risk of needlestick injuries. Streck’s February 2022 launch of RNA Complete BCT enabled extended RNA preservation for up to seven days at room temperature, ensuring better sample stability during storage and transport.
Investments and Collaborations Fueling Market Growth
Global market players are increasingly focusing on partnerships, funding, and technological collaborations to enhance product development and expand their portfolio of innovative blood collection devices. In May 2022, Becton, Dickinson and Company (BD) extended its collaboration with Babson Diagnostics to advance less-invasive, self-collection blood devices. In December 2021, Tasso secured $100 million in funding to scale up production of its OnDemand capillary blood collection system, which uses a simple push-button mechanism for at-home sampling. Earlier, in May 2019, Velano Vascular received a $10 million investment from Intermountain Healthcare to accelerate commercialization of its needle-free blood collection solution, highlighting the growing interest in patient-friendly diagnostic technologies.
Challenges Hindering Market Growth
Despite the positive outlook, the blood collection devices market faces certain challenges. Common issues include incomplete sealing of tubes leading to microbial contamination, and chemical interference affecting test accuracy. These problems have led to several product recalls over the years. For example, in November 2021, Velano Vascular recalled its PIVO Blood Collection Device due to contamination risks caused by inadequate sealing. In June 2019, BD recalled Vacutainer PST Gel and LH Blood Collection Tubes after reports of false COHb results. Similarly, in May 2018, BD issued a large-scale recall of over 982 million venous collection tubes for chemical interference with ASV-based tests. Other restraints include the high cost of automated systems, maintenance requirements, and logistical complexities in storage and transport. However, ongoing technological advancements—such as the integration of AI, ultrasound guidance, and extended storage stability—are expected to overcome these barriers and sustain steady market growth.
Competitive Landscape and Future Outlook
The Blood Collection Devices Market is characterized by the presence of major players including Becton, Dickinson and Company (US), Terumo BCT (US), Haemonetics Corporation (US), Grifols S.A. (Spain), and Fresenius Kabi AG (Germany). These companies are focusing on innovation, product diversification, and strategic partnerships to maintain competitiveness. Going forward, advancements in automation, robotics, and smart diagnostics are likely to redefine blood collection practices, improving safety, efficiency, and accessibility. As demand for minimally invasive and home-based blood collection solutions continues to rise, the market is expected to experience sustained momentum through 2026 and beyond.
Download pdf Brochure: https://meditechinsights.com/blood-collection-devices-market/request-sample/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply
